InsiderClue

Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 1/25
PBYI
Result 263 decisions over 120 months
Reset filters
Direction ?
Both263 Bought1 Sold262
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo 120 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Company: PBYI
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
PBYI PUMA BIOTECHNOLOGY, INC.
8 Jun 2017
ADAGE CAPITAL PARTNERS GP, L.L.C.
10% owner indirect
Sold, plan not stated 2×
100,000
$8.09M
2.5%
PBYI PUMA BIOTECHNOLOGY, INC.
5 Jun 2017
ADAGE CAPITAL PARTNERS GP, L.L.C.
10% owner indirect
Sold, plan not stated 7×
307,128
$28.04M
7.2%
PBYI PUMA BIOTECHNOLOGY, INC.
2 Jun 2017
ADAGE CAPITAL PARTNERS GP, L.L.C.
10% owner indirect
Sold, plan not stated
30,475
$2.53M
0.7%
PBYI PUMA BIOTECHNOLOGY, INC.
1 Jun 2017
ADAGE CAPITAL PARTNERS GP, L.L.C.
10% owner indirect
Sold, plan not stated 2×
169,525
$13.98M
3.8%
PBYI PUMA BIOTECHNOLOGY, INC.
26 May 2017
ADAGE CAPITAL PARTNERS GP, L.L.C.
10% owner indirect
Sold, plan not stated 3×
300,000
$23.12M
6.3%
PBYI PUMA BIOTECHNOLOGY, INC.
25 May 2017
ADAGE CAPITAL PARTNERS GP, L.L.C.
10% owner indirect
Sold, plan not stated 4×
400,000
$31.15M
7.8%
PBYI PUMA BIOTECHNOLOGY, INC.
24 May 2017
ADAGE CAPITAL PARTNERS GP, L.L.C.
10% owner indirect
Sold, plan not stated 7×
535,700
$38.88M
9.4%
PBYI PUMA BIOTECHNOLOGY, INC.
1 Feb 2017
CHARNAS ROBERT
See Remarks
Sold, plan not stated 2×
3,008
$95.75K
10.2%
PBYI PUMA BIOTECHNOLOGY, INC.
20 Jan 2017
AUERBACH ALAN H
PRESIDENT AND CEO
Sold, plan not stated
10,202
$339.06K
0.2%
PBYI PUMA BIOTECHNOLOGY, INC.
20 Jan 2017
CHARNAS ROBERT
See Remarks
Sold, plan not stated
2,293
$76.21K
7.2%
PBYI PUMA BIOTECHNOLOGY, INC.
20 Jan 2017
BRYCE RICHARD PAUL
SR VP, CLINICAL RESEARCH & DEV
Sold, plan not stated
2,293
$76.21K
7.3%
PBYI PUMA BIOTECHNOLOGY, INC.
20 Jan 2017
Lo Steven
Chief Commercial Officer
Sold, plan not stated
2,290
$76.11K
7.3%
PBYI PUMA BIOTECHNOLOGY, INC.
20 Jan 2017
EYLER CHARLES R
SEE REMARKS
Sold, plan not stated
820
$27.25K
7.8%
Showing 251–263 of 263. ← Newer Page 6 of 6